Global Retinopathy Of Prematurity Therapeutics Market Research Report 2024

Report ID: 1977711 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 IB-09A0133
        1.2.3 Mecasermin Rinfabate
        1.2.4 Propranolol
        1.2.5 R-200
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Retinopathy Of Prematurity Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Home Care
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Retinopathy Of Prematurity Therapeutics Market Perspective (2018-2029)
    2.2 Retinopathy Of Prematurity Therapeutics Growth Trends by Region
        2.2.1 Global Retinopathy Of Prematurity Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Retinopathy Of Prematurity Therapeutics Historic Market Size by Region (2018-2023)
        2.2.3 Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Region (2024-2029)
    2.3 Retinopathy Of Prematurity Therapeutics Market Dynamics
        2.3.1 Retinopathy Of Prematurity Therapeutics Industry Trends
        2.3.2 Retinopathy Of Prematurity Therapeutics Market Drivers
        2.3.3 Retinopathy Of Prematurity Therapeutics Market Challenges
        2.3.4 Retinopathy Of Prematurity Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Retinopathy Of Prematurity Therapeutics Players by Revenue
        3.1.1 Global Top Retinopathy Of Prematurity Therapeutics Players by Revenue (2018-2023)
        3.1.2 Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Players (2018-2023)
    3.2 Global Retinopathy Of Prematurity Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Retinopathy Of Prematurity Therapeutics Revenue
    3.4 Global Retinopathy Of Prematurity Therapeutics Market Concentration Ratio
        3.4.1 Global Retinopathy Of Prematurity Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Retinopathy Of Prematurity Therapeutics Revenue in 2022
    3.5 Retinopathy Of Prematurity Therapeutics Key Players Head office and Area Served
    3.6 Key Players Retinopathy Of Prematurity Therapeutics Product Solution and Service
    3.7 Date of Enter into Retinopathy Of Prematurity Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Retinopathy Of Prematurity Therapeutics Breakdown Data by Type
    4.1 Global Retinopathy Of Prematurity Therapeutics Historic Market Size by Type (2018-2023)
    4.2 Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Type (2024-2029)
5 Retinopathy Of Prematurity Therapeutics Breakdown Data by Application
    5.1 Global Retinopathy Of Prematurity Therapeutics Historic Market Size by Application (2018-2023)
    5.2 Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Retinopathy Of Prematurity Therapeutics Market Size (2018-2029)
    6.2 North America Retinopathy Of Prematurity Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023)
    6.4 North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Retinopathy Of Prematurity Therapeutics Market Size (2018-2029)
    7.2 Europe Retinopathy Of Prematurity Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023)
    7.4 Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size (2018-2029)
    8.2 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2018-2023)
    8.4 Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Retinopathy Of Prematurity Therapeutics Market Size (2018-2029)
    9.2 Latin America Retinopathy Of Prematurity Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023)
    9.4 Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size (2018-2029)
    10.2 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023)
    10.4 Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Biomar Microbial Technologies
        11.1.1 Biomar Microbial Technologies Company Detail
        11.1.2 Biomar Microbial Technologies Business Overview
        11.1.3 Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Introduction
        11.1.4 Biomar Microbial Technologies Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
        11.1.5 Biomar Microbial Technologies Recent Development
    11.2 D. Western Therapeutics Institute Inc
        11.2.1 D. Western Therapeutics Institute Inc Company Detail
        11.2.2 D. Western Therapeutics Institute Inc Business Overview
        11.2.3 D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Introduction
        11.2.4 D. Western Therapeutics Institute Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
        11.2.5 D. Western Therapeutics Institute Inc Recent Development
    11.3 F. Hoffmann-La Roche Ltd
        11.3.1 F. Hoffmann-La Roche Ltd Company Detail
        11.3.2 F. Hoffmann-La Roche Ltd Business Overview
        11.3.3 F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Introduction
        11.3.4 F. Hoffmann-La Roche Ltd Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
        11.3.5 F. Hoffmann-La Roche Ltd Recent Development
    11.4 Insmed Inc
        11.4.1 Insmed Inc Company Detail
        11.4.2 Insmed Inc Business Overview
        11.4.3 Insmed Inc Retinopathy Of Prematurity Therapeutics Introduction
        11.4.4 Insmed Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
        11.4.5 Insmed Inc Recent Development
    11.5 Recordati SpA
        11.5.1 Recordati SpA Company Detail
        11.5.2 Recordati SpA Business Overview
        11.5.3 Recordati SpA Retinopathy Of Prematurity Therapeutics Introduction
        11.5.4 Recordati SpA Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
        11.5.5 Recordati SpA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of IB-09A0133
    Table 3. Key Players of Mecasermin Rinfabate
    Table 4. Key Players of Propranolol
    Table 5. Key Players of R-200
    Table 6. Key Players of Others
    Table 7. Global Retinopathy Of Prematurity Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Retinopathy Of Prematurity Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Retinopathy Of Prematurity Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Retinopathy Of Prematurity Therapeutics Market Share by Region (2018-2023)
    Table 11. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Retinopathy Of Prematurity Therapeutics Market Share by Region (2024-2029)
    Table 13. Retinopathy Of Prematurity Therapeutics Market Trends
    Table 14. Retinopathy Of Prematurity Therapeutics Market Drivers
    Table 15. Retinopathy Of Prematurity Therapeutics Market Challenges
    Table 16. Retinopathy Of Prematurity Therapeutics Market Restraints
    Table 17. Global Retinopathy Of Prematurity Therapeutics Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Retinopathy Of Prematurity Therapeutics Market Share by Players (2018-2023)
    Table 19. Global Top Retinopathy Of Prematurity Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinopathy Of Prematurity Therapeutics as of 2022)
    Table 20. Ranking of Global Top Retinopathy Of Prematurity Therapeutics Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Retinopathy Of Prematurity Therapeutics Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Retinopathy Of Prematurity Therapeutics Product Solution and Service
    Table 24. Date of Enter into Retinopathy Of Prematurity Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Retinopathy Of Prematurity Therapeutics Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2018-2023)
    Table 28. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Type (2024-2029)
    Table 30. Global Retinopathy Of Prematurity Therapeutics Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application (2018-2023)
    Table 32. Global Retinopathy Of Prematurity Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Retinopathy Of Prematurity Therapeutics Revenue Market Share by Application (2024-2029)
    Table 34. North America Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Biomar Microbial Technologies Company Detail
    Table 50. Biomar Microbial Technologies Business Overview
    Table 51. Biomar Microbial Technologies Retinopathy Of Prematurity Therapeutics Product
    Table 52. Biomar Microbial Technologies Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023) & (US$ Million)
    Table 53. Biomar Microbial Technologies Recent Development
    Table 54. D. Western Therapeutics Institute Inc Company Detail
    Table 55. D. Western Therapeutics Institute Inc Business Overview
    Table 56. D. Western Therapeutics Institute Inc Retinopathy Of Prematurity Therapeutics Product
    Table 57. D. Western Therapeutics Institute Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023) & (US$ Million)
    Table 58. D. Western Therapeutics Institute Inc Recent Development
    Table 59. F. Hoffmann-La Roche Ltd Company Detail
    Table 60. F. Hoffmann-La Roche Ltd Business Overview
    Table 61. F. Hoffmann-La Roche Ltd Retinopathy Of Prematurity Therapeutics Product
    Table 62. F. Hoffmann-La Roche Ltd Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023) & (US$ Million)
    Table 63. F. Hoffmann-La Roche Ltd Recent Development
    Table 64. Insmed Inc Company Detail
    Table 65. Insmed Inc Business Overview
    Table 66. Insmed Inc Retinopathy Of Prematurity Therapeutics Product
    Table 67. Insmed Inc Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023) & (US$ Million)
    Table 68. Insmed Inc Recent Development
    Table 69. Recordati SpA Company Detail
    Table 70. Recordati SpA Business Overview
    Table 71. Recordati SpA Retinopathy Of Prematurity Therapeutics Product
    Table 72. Recordati SpA Revenue in Retinopathy Of Prematurity Therapeutics Business (2018-2023) & (US$ Million)
    Table 73. Recordati SpA Recent Development
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Retinopathy Of Prematurity Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Retinopathy Of Prematurity Therapeutics Market Share by Type: 2022 VS 2029
    Figure 3. IB-09A0133 Features
    Figure 4. Mecasermin Rinfabate Features
    Figure 5. Propranolol Features
    Figure 6. R-200 Features
    Figure 7. Others Features
    Figure 8. Global Retinopathy Of Prematurity Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Retinopathy Of Prematurity Therapeutics Market Share by Application: 2022 VS 2029
    Figure 10. Hospital Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Home Care Case Studies
    Figure 13. Retinopathy Of Prematurity Therapeutics Report Years Considered
    Figure 14. Global Retinopathy Of Prematurity Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 15. Global Retinopathy Of Prematurity Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 16. Global Retinopathy Of Prematurity Therapeutics Market Share by Region: 2022 VS 2029
    Figure 17. Global Retinopathy Of Prematurity Therapeutics Market Share by Players in 2022
    Figure 18. Global Top Retinopathy Of Prematurity Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinopathy Of Prematurity Therapeutics as of 2022)
    Figure 19. The Top 10 and 5 Players Market Share by Retinopathy Of Prematurity Therapeutics Revenue in 2022
    Figure 20. North America Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. North America Retinopathy Of Prematurity Therapeutics Market Share by Country (2018-2029)
    Figure 22. United States Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Canada Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Retinopathy Of Prematurity Therapeutics Market Share by Country (2018-2029)
    Figure 26. Germany Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. France Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. U.K. Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Italy Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Russia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Nordic Countries Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Retinopathy Of Prematurity Therapeutics Market Share by Region (2018-2029)
    Figure 34. China Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Japan Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. South Korea Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Southeast Asia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. India Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Australia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Retinopathy Of Prematurity Therapeutics Market Share by Country (2018-2029)
    Figure 42. Mexico Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Brazil Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Retinopathy Of Prematurity Therapeutics Market Share by Country (2018-2029)
    Figure 46. Turkey Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Saudi Arabia Retinopathy Of Prematurity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Biomar Microbial Technologies Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
    Figure 49. D. Western Therapeutics Institute Inc Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
    Figure 50. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
    Figure 51. Insmed Inc Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
    Figure 52. Recordati SpA Revenue Growth Rate in Retinopathy Of Prematurity Therapeutics Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Biomar Microbial Technologies
D. Western Therapeutics Institute Inc
F. Hoffmann-La Roche Ltd
Insmed Inc
Recordati SpA
Frequently Asked Questions
Retinopathy Of Prematurity Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Retinopathy Of Prematurity Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Retinopathy Of Prematurity Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

SDHI Fungicide

This report aims to provide a comprehensive presentation of the global market for SDHI Fungicide, ... Read More